Academy Criticism Of A Foreign Associate Stirs Debate Over NAS Role And Policies

Controversy centers on whether and how the elite science body should deal with members whose behavior is questionable For the first time in its 129-year history, the National Academy of Sciences has sent a letter to one of its members hinting that he should resign. The unprecedented move has called into question the academy's role as an ostensibly apolitical body. The ensuing debate has focused on, among other issues, whether NAS should censure its members whose activities are offensive to a l

Written byBarbara Spector
| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share


Controversy centers on whether and how the elite science body should deal with members whose behavior is questionable
For the first time in its 129-year history, the National Academy of Sciences has sent a letter to one of its members hinting that he should resign. The unprecedented move has called into question the academy's role as an ostensibly apolitical body. The ensuing debate has focused on, among other issues, whether NAS should censure its members whose activities are offensive to a large group of people, what evidence is necessary to prompt such censure, and whether it is proper for the NAS council, without first consulting the academy's grass roots, to confront members it believes have violated "what the National Academy stands for," in the words of the academy's foreign secretary, James B. Wyngaarden.

The letter, signed by NAS president Frank Press and by Wyngaarden, was delivered in July to Russian ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies